Media Room

Agilent at AACR 2026

Agilent will highlight scientific innovations and partnerships in the areas of cancer research, integrated workflows, companion diagnostics, digital/spatial pathology, and more at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2026 in San Diego, California.

AACR 2026

Every Day Counts in the Race Against Cancer

Agilent is dedicated to pushing the boundaries of cancer research and diagnostics.

Our innovative solutions and strategic partnerships are at the forefront of transforming cancer care, enabling us to deliver comprehensive multiomic insights and cutting-edge diagnostic tools that empower researchers and clinicians to make more informed decisions and ultimately improve patient care. Whether your early discovery research, clinical trials or diagnostic tools development, Agilent is there to support scientists with an integrated portfolio of solutions. 

 


New Product Introductions

Coming soon!

Discover the next generation of hybrid analysis—advancing what’s possible in automated cell imaging and detection.

Visit Booth #4527 at AACR and be one of the first to learn more. 
 

Agilent Accelerates Digital Pathology with the Launch of the Agilent S540MD Slide Scanner System


Exhibitor Spotlight Session

Direct Targeted Methylation Sequencing (dTMS) with SureSelect: targeted long-read sequencing for native variant and methylation profiling in oncology

Presented by: Andrew Jenkins, Biotechnology Research Associate, Wasatch Biolabs

Date: Monday, April 20, 2026

Time: 10:00 AM - 11:00 AM PST

Location: Theater D


Runners 4 Research 5k

Agilent is participating in the annual Runners 4 Research 5K.


Join our team


Agilent Cancer Research 5K 2026

AACR meeting attendees can get an early bird discount for signing up at the conference.


Register Now


xCELLigence Cancer & Immunotherapy Symposium

Learn more about the work being done by the incredible speakers listed below: 
 

Super‑charged NK cells increase immune infiltration in the tumor microenvironment and inhibit tumor growth 
Presented by: Dr. Kawaljit Kaur, CEO, ImmuneLink; Scientific Advisor on NK cells and/or cell‑based immunotherapies; Biotech Investor
 

The impact of microbial-derived metabolites on innate immune cell anti‑cancer activities
Presented by: Dr. Katherine Cook, Associate Professor, Wake Forest University
 

Strategies to overcome breast-to-brain metastasis
Presented by: Dr. David Soto-Pantoja, Associate Professor / Principal Investigator, Wake Forest University
 

Event Details: 

Date: Saturday April 18, 2025 

Time: 1:00 PM - 6:00 PM

Location: University of California San Diego Campus

Theatre District – Survivance 1126 conference room 11th floor of the Survivance Building


Register Now